Mallinckrodt Public Profile

USD 0.51  2.39%

Acquisition by Frank Scholz of 3711 shares of Mallinckrodt Public subject to Rule 16b-3

Mallinckrodt Public Limited Company insider trading alert for grant of ordinary shares by Frank Scholz, SVP Global Operations, on January 21, 2018. This event was filed by Mallinckrodt Plc with SEC on 2014-04-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Mallinckrodt Public Summary

Mallinckrodt Public Limited Company (MNK) is traded on New York Stock Exchange in USA. It is located in IRELAND and employs 4,500 people. Mallinckrodt Public is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 2.02 B. Mallinckrodt Public Limited Company runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 95 M outstanding shares of which 22.29 M shares are now shorted by investors with about 4.76 days to cover shorted positions. ML NIKKEI225 MITT has about 373.4 M in cash with 357.7 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.93.
Check Mallinckrodt Public Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Mallinckrodt Public Limited Company Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Mallinckrodt Public Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 48% 
Equity ratings for Mallinckrodt Public Limited Company are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical solutions and therapies in the United States, Europe, the Middle East, Africa, and internationally. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMallinckrodt Public Limited Company
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
Business AddressChesterfield, S ND
ExchangeNew York Stock Exchange
IndustryPharmaceuticals And Biosciences
Contact Number44 4246 263 051
CurrencyUSD - US Dollar


Mallinckrodt Public Analyst Recommendations
Target PriceAdvice# of Analysts
Mallinckrodt Public Limited Company current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Mallinckrodt Public Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Mallinckrodt Public Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.64May 2, 2017
Mallinckrodt Public Limited Company normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate